Remote Patient Monitoring Market Trends and Insights by Type (Devices [Blood Glucose Monitoring, Respiratory Monitoring, Cardiac Monitoring, Multi-parameter Monitoring, and Others], Services), by Application (Cancer, Cardiovascular Diseases, Diabetes, and Others), by End User (Payers, Providers, and Patients), by Region (North America, Europe, Asia-Pacific, and Rest of the World), Competitive Market Growth, Size, Share and Forecast to 2030
New York, USA, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Remote Patient Monitoring Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Remote Patient Monitoring Market Information By Application, Type, End User, And Region - Forecast till 2030", the market will touch USD 6.42 billion by 2030, an 18.64% CAGR during the forecast period 2022-2030.
Remote Patient Monitoring Market Synopsis
The technique of remotely monitoring and gathering physiological and other patient data using digital tools is known as remote patient monitoring (RPM). Patients that require chronic, post-discharge or geriatric care are typically helped by RPM. It can alert healthcare companies about potential health risks or keep track of patient information between visits by connecting high-risk patients with remote monitoring. Businesses that want to track workmen's compensation cases may also use RPM to ensure that workers are on the right road to returning to work. Patients, particularly the elderly, those recovering from surgery, those suffering from chronic illnesses, and those with impairments, can obtain medical evaluations at home thanks to remote patient monitoring technology.
The enhanced chronic illness management provided by remote monitoring systems and early warning indications and progress trackers will increase demand for these systems globally in the upcoming years. Real-time patient data via remote patient monitoring has helped with the timely management of chronic obstructive pulmonary disease, cancer, and diabetes. By reducing the distance between the patient and the healthcare provider, the implementation or adoption of next-generation sensor technology has impacted healthcare systems.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/10905
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
By Type, Application, and End User
North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Increasing geriatric population and Growing investments in telehealth
Rising prevalence of chronic diseases
Remote Patient Monitoring Market Competitive Landscape:
The stellar contenders in the remote patient monitoring market are:
Koninklijke Philips N.V. (Netherlands)
Remote Patient Monitoring Market U.S.P. Covered:
The growing geriatric population is one of the main factors boosting the market's demand. RPM technology can help seniors prevent chronic problems from worsening and ensure their rehabilitation continues long after they leave an acute care facility. RPM technology can also alert medical staff and take appropriate action when an elderly person is wounded or in danger. Recent developments in remote monitoring capabilities are anticipated to support market expansion during the forecast period. Some advancements include the integration of RPM into hospitals around the world, using Artificial Intelligence (AI) to enhance clinical decision making, and functional enhancements, including a decrease in false alarms. Commercial businesses are also attempting to incorporate RPM into their goods.
Incorporating IoT elements into medical equipment has made it possible to provide patients and the older population with chronic illnesses with better quality and more efficient care. Sensors, Bluetooth connectivity, actuators, and other communication tools have made it effortless for patients and caregivers to communicate data to the doctor via a cloud-based platform.
Remote Patient Monitoring Market Restraints:
The growth of the remote patient monitoring business is being constrained by the potential for data breaches and worries about data privacy. The patient's information cannot be disclosed by medical professionals who have access to the remote patient monitoring data to anybody who is not directly involved in the patient's care. Thus, it is crucial to maintain data confidentiality. Recent data breaches have eroded end users' faith in the products. Despite the rising need for solutions, it is projected that the lack of device and software adoption in low- and middle-income nations will restrain market growth throughout the projection period. One aspect of the drop in usage in these nations is the high implementation cost of remote patient monitoring systems. The adoption of these solutions needs appropriate funding, providers, and IT staff to ensure a smooth transition and the provision of high-quality patient care.
Browse In-depth Market Research Report (120 Pages) on Remote Patient Monitoring: https://www.marketresearchfuture.com/reports/remote-patient-monitoring-market-10905
Remote Patient Monitoring Market COVID 19 Analysis
The call for remote patient monitoring services has been considerably impacted by COVID-19. This was because of measures taken during the pandemic to stop the virus' transmission, such as lockdowns, social withdrawal, and travel restrictions. Consequently, this made it very challenging for patients to attend healthcare facilities and undergo an on-site medical evaluation. As a result, there was a sharp rise in the need for reliable remote patient monitoring systems to deal with the pandemic's disruptions.
Additionally, it contributed to users becoming more aware of the benefits of remote patient monitoring. This has also prompted large investments in the industry, which are fueling market expansion. The COVID-19 pandemic has prompted the adoption of cutting-edge technological solutions that can assist with managing medications, tracking disease symptoms, and remote monitoring of vital signs. More health parameters can be examined as the next-generation patient monitoring solutions grow more comprehensive.
Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=10905
Remote Patient Monitoring Market Segmentation
Device sales are mostly driven by new product introductions and rising innovation rates.
Cardiovascular problems frequently include the usage of RPM products and services.
Due to rising disease prevalence, per capita income, and healthcare awareness, the patient sector is anticipated to account for a sizeable portion of the market.
Remote Patient Monitoring Market Regional Insights
By region, North America's remote patient monitoring market had the biggest share. The rising prevalence of chronic diseases is a significant factor in the rise in demand for RPM goods and services. RPM is most commonly used in heart problems because sedentary lifestyles are becoming increasingly popular. As a result, these elements assisted North America in securing the biggest market share. Due to good legislative conditions, sufficient healthcare infrastructure, and the quick uptake of the devices, Europe retained the second position in the market.
Share your Queries @ https://www.marketresearchfuture.com/enquiry/10905
Additionally, introducing these monitoring devices in the region facilitates greater adoption thanks to strategic alliances amongst the businesses to offer patients full-service remote patient monitoring. Due to the existence of unexplored potential in the rising markets of India and China, the Asia-Pacific market is anticipated to see the quickest CAGR over the forecast period. Japan's large elderly population is predicted to be a major source of income.
Discover more research Reports on Healthcare Industry, by Market Research Future:
Bariatric Surgery Market Research Report: by device (surgical stapler, gastric bands, gastric balloons, adjustable gastric band, and gastric emptying systems), by type (gastric bypass and sleeve gastrectomy), by the end user - Global forecast till 2030
Narcolepsy Market Research Report, By Type (Type 1, Type 2 Narcolepsy) Diagnosis (Poysomnogram, Multiple Sleep Latency Test) Treatment (Stimulants, Antidepressants, Sodium Oxybate) End Users (Hospitals, Retail Pharmacies) – Global Forecast Till 2027
DNA Sequencing Market Research Report: By Type (Workflow Products and Others), Product (Sequencing Services and Others), Technology (Semiconductor Sequencing and Others), Application (Diagnostics and Others), End- Forecast Till 2027
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
UNITY Biotechnology Inc (NASDAQ: UBX) shares are skyrocketing after 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325 for diabetic macular edema (DME). DME is a diabetic complication that affects the blood vessels in the back of your eye. At 18 weeks after a single UBX1325 injection, the mean change in BCVA of UBX1325-treated subjects was an increase of 6.1 ETDRS letters, representing an improvement of +5.0 ETDRS letters compared to sham-treated subjects. Related: UNITY Biotech Stock
Vaxxinity missed out on Operation Warp Speed and the first round of COVID-19 vaccines, but CEO Mei Mei Hu is focused on the second generation and ongoing global needs.
New drugs from Eli Lilly and Novo Nordisk have shown striking results in studies. If insurers step up to back them, the drugs—and the stocks—could take off.
The U.S. Centers For Disease Control and Prevention has relaxed some guidelines around COVID-19, including the quarantine recommendation for people who have been exposed. Officials say the new guidelines are meant to educate people on how to stay safe without causing much disruption to life, school and work.
Aptinyx (APTX) reports disappointing data from a mid-stage study assessing NYX-2925 for the treatment of fibromyalgia. Stocks decline
Big pharma stocks, such as Glaxo (GSK), Sanofi (SNY), Pfizer (PFE) and Consumer stock Haleon (HLN), decline due to the litigation surrounding the heartburn drug Zantac (ranitidine).
Pfizer (PFE) offers to buy Global Blood Therapeutics (GBT) for $5.4 billion in cash. J&J (JNJ) to discontinue selling talc-based baby powder globally from 2023.
(TSX: CWEB) (OTC: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web," "CW" or the "Company"), the market leader in full-spectrum hemp extract CBD products, today announced plans to unveil a product line catering to the sports vertical. The products are currently undergoing the NSF for Sport® certification process with NSF, a third-party organization that manufacturers, regulators, and consumers look to for the development of public health standards and certification marks that help protect
The FTSE 100 pharmaceutical giant's share price suffered its biggest drop since 1998 on Thursday.
Friends up north and across Tampa Bay snickered when Brian Lafferty revealed where he’d bought a new home. His 30-year-old daughter in Boston called to express concern. Even his ex-wife asked him about it. “Without exception, every person I’ve told I bought a house in The Villages has asked the same thing,” Lafferty said. “‘Isn’t that the STD capital of the United States?’” The Villages, a ...
Vedanta, a microbiome startup that raised $68 million just over a year ago is letting about 20% of its staff go.
Only 65% of Black adults aged 50 and older are up-to-date with potentially life-saving colorectal cancer screening. We proudly supported the development of the National Colorectal Cancer Roundtable...
With CDC relaxing COVID-19 guidelines, you can still shop KN95 face masks for better protection—shop face masks from Amazon, Maskc, Vida and more.
The nation's top public health agency relaxed its COVID-19 guidelines Thursday, dropping the recommendation that Americans quarantine themselves if they come into close contact with an infected person. The Centers for Disease Control and Prevention also said people no longer need to stay at least 6 feet away from others. “The current conditions of this pandemic are very different from those of the last two years,” said the CDC's Greta Massetti, an author of the guidelines.
Joining me on today's call are RA Session II Taysha's president, founder, and CEO; Dr. Frederick Porter, chief technical officer; Dr. Suyash Prasad, chief medical officer and head of R&D and Kamran Alam, chief financial officer. After our formal remarks, we will conduct a question-and-answer session and instructions will follow at that time.
Dr. Bill Hartman with UW Health joined FOX6 to discuss the latest COVID-19 developments, including the Novavax vaccine.
The Pensacola community has been mourning the death of SCI business director Rodney Jackson from Vibrio. Here's what to know about the bacteria.
The latest guidance aligns with the recommendations set for those who are up to date on their COVID-19 vaccines
Salt Lake County Council member Dave Alvord sure has some *thoughts* about reproductive health.
After a UBS analyst's note sparked a two-day plunge in the drug makers, their shares rallied Friday after they said there is no evidence the heartburn drug causes cancer.